1 / 1

Figure S1

Figure S1. A. B. *. *. GLI1/GAPDH mRNA. Survival (%). Vehicle m=61d MBZ m=80d. **. Treatment Time (Days). Supplementary Fig S1 .

Télécharger la présentation

Figure S1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Figure S1 A B * * GLI1/GAPDH mRNA Survival (%) Vehicle m=61dMBZ m=80d ** Treatment Time (Days) Supplementary Fig S1. (A) Survival of mice with DAOY-derived orthotopic tumors at 25 mg/kg MBZ (n=4) or mock-treated (n=3). One mouse from the mock treatment group did not develop symptoms of a growing brain tumor, and was euthanized after surviving for more than six months. This mouse was not found to have a brain tumor, and was therefore omitted from this analysis. (B) RNA was harvested from untreated and treated tumors and assessed by qRT-PCR for expression of GLI1, PTCH1, and PTCH2.

More Related